🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Vegan Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
75% Evidence Coverage

Supplement Facts — Evidence Check

500 mg
📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)
This product: 500mg
GABA
250 mg
Vitamin C
220 mg (244.44% DV)
200 mg
📊 Market median: 300.0mg (214 products) 📚 23 studies (Tier A: 0, B: 6)
This product: 200mg
6 mg (54.55% DV)
✅ Within RDA (0.5× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 6mg UL 40mg
📊 Market median: 450.0mg (502 products) 📚 28 studies (Tier A: 0, B: 8)
This product: 150mg
1.5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 1.5mg UL 10mg
📊 Market median: 80.0mg (20 products) 📚 334 studies (Tier A: 8, B: 183)
This product: 225mg

Other Ingredients

Hypromellose Rice Flour Magnesium Stearate

Label Claims — Verification

Structure/Function
All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

🧪 Formulation Notes

Overnight prostate health formula Promote great sleep Improve immune function Decrease stress levels

Additional Information

Nothing compares

Product Details

DSLD Entry Date 2021-03-25
Product Type Other Combinations
Form Capsule
Brand 1st Phorm
DSLD ID 242735
Data Updated 2026-04-11

Research Evidence

35 Research Sources
52 Avg Quality Score
15 Meta Analysis
11 Systematic Review
7 Rct
1 Narrative Review
1 Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009
View all evidence for Saw Palmetto →

Compare Similar Products

View all Saw Palmetto products →